Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/26/2025

Diagnostic Testing for Pertussis

Clinical Diagnosis

  • The Centers for Disease Control and Prevention (CDC) suspect pertussis when a patient has a cough lasting >2 weeks without another apparent cause, accompanied by paroxysms of coughing, post-tussive vomiting, and/or an inspiratory whooping sound 1, 2
  • A clinical case is defined as an acute illness with cough persisting for >2 weeks associated with post-tussive vomiting, typical whooping sound, or severe paroxysms 3

Diagnostic Testing Algorithm

  • The CDC recommends collecting nasopharyngeal aspirate or using a Dacron swab of the nasopharynx for culture as the initial test to confirm the presence of Bordetella pertussis 1, 4
  • Culture is 100% specific but has variable sensitivity (30-60% in practice) 5, 6
  • The CDC states that sensitivity decreases after 2+ weeks of cough illness 3, antimicrobial treatment 7, or previous pertussis vaccination 5, 6
  • Culture requires 1-2 weeks for definitive negative results 5
  • Despite limitations, culture remains essential for antimicrobial susceptibility testing and molecular subtyping 5, 6
  • The CDC endorses PCR for diagnosis only when the clinical case definition is also met (>2 weeks of cough with paroxysms, inspiratory "whoop," or post-tussive vomiting) 8, 9
  • PCR has increased sensitivity (80-100%) and shorter turn-around time compared to culture 1, 5
  • PCR is 2-3 times more likely than culture to detect B. pertussis when classic symptoms are present 5, 6

Timing Considerations

  • The CDC recommends beginning testing as early as possible in the course of illness 1, 4
  • Culture sensitivity drops significantly after 3 weeks of cough (only 1-3% sensitive) 5

Confirmed Diagnosis Criteria

  • The CDC defines a confirmed diagnosis as isolation of B. pertussis from nasopharyngeal culture, or a clinical case with PCR confirmation, or a clinical case with epidemiologic linkage to a confirmed case 1, 2

Treatment Considerations

  • The CDC recommends not delaying treatment while awaiting test results 1, 7
  • Early treatment (within first 2 weeks) will rapidly clear B. pertussis from the nasopharynx and decrease coughing paroxysms 1, 7
  • Patients should be isolated for 5 days after starting antibiotic therapy 1, 7

Diagnosis of Pertussis After Antibiotic Treatment

Diagnostic Methods

  • The Centers for Disease Control and Prevention recommends nasopharyngeal PCR as the gold standard investigation for pertussis after 2 days of antibiotics, as culture sensitivity drops dramatically after antibiotic initiation, while PCR remains 2-3 times more sensitive than culture even in treated patients 10
  • Culture sensitivity declines significantly after antimicrobial treatment, making it unreliable after 2 days of antibiotics, with typical sensitivity dropping from 30-60% to even lower levels 10
  • PCR maintains superior sensitivity even after antibiotic initiation, detecting B. pertussis 2-3 times more effectively than culture when classic pertussis symptoms are present 10
  • PCR provides rapid turnaround time (results within 24-48 hours) compared to culture which requires 1-2 weeks for definitive negative results 10
  • Nasopharyngeal specimens should be collected using a Dacron swab or nasopharyngeal aspirate for optimal PCR testing 11

Infection Control and Treatment

  • Blood culture has no role in pertussis diagnosis, as B. pertussis does not cause bacteremia and remains localized to the respiratory tract 10
  • Single-sample serology is not endorsed by the CDC for routine diagnostic use because it cannot differentiate between recent infection, remote infection, or vaccination response 10
  • Serology requires paired acute and convalescent sera showing a fourfold rise in antibody titers, with results becoming available too late (weeks) to guide acute management 10, 11
  • Patients should be isolated for 5 days after starting antibiotic therapy regardless of test results 11

Optimal Specimen Collection and Testing for Bordetella pertussis PCR

Swab Selection

  • Use Dacron (or rayon) nasopharyngeal swabs for both PCR and culture – the CDC explicitly recommends Dacron swabs, and laboratory validation studies have shown they do not inhibit PCR amplification. 12
  • Nasopharyngeal aspirates provide higher culture yield than swabs – in comparative testing, aspirates were positive in 30 of 33 specimens versus 26 of 33 for swabs, and they allow the sample to be split for multiple assays. 13

Specimen Collection Technique

  • Collect the specimen from the posterior nasopharynx rather than the anterior nares, because B. pertussis colonizes the nasopharyngeal mucosa. 12
  • Avoid anterior‑only nasal specimens, as limiting collection to the anterior nose markedly reduces diagnostic yield. 13

Diagnostic Testing Recommendations

  • The CDC endorses PCR as the primary diagnostic test when clinical criteria are met (cough > 2 weeks with paroxysms, whooping, or post‑tussive vomiting), superseding the 2006 ACCP guideline that advised against PCR due to lack of validated techniques. 12

Comparative Performance of PCR vs. Culture

Metric PCR Culture
Sensitivity (clinical practice) 80–100 % 30–60 %
Turn‑around time 24–48 h 1–2 weeks
Performance in older, vaccinated, or antibiotic‑treated patients Maintained Significantly reduced

These figures reflect the CDC’s assessment of PCR’s superior sensitivity, faster results, and robustness across patient subgroups. 13

REFERENCES